JP2006503031A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006503031A5 JP2006503031A5 JP2004535695A JP2004535695A JP2006503031A5 JP 2006503031 A5 JP2006503031 A5 JP 2006503031A5 JP 2004535695 A JP2004535695 A JP 2004535695A JP 2004535695 A JP2004535695 A JP 2004535695A JP 2006503031 A5 JP2006503031 A5 JP 2006503031A5
- Authority
- JP
- Japan
- Prior art keywords
- epa
- use according
- administered
- day
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims 11
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims 11
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims 11
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims 11
- 208000000103 Anorexia Nervosa Diseases 0.000 claims 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 2
- 125000004494 ethyl ester group Chemical class 0.000 claims 2
- 208000032841 Bulimia Diseases 0.000 claims 1
- 206010006550 Bulimia nervosa Diseases 0.000 claims 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims 1
- 229940090949 docosahexaenoic acid Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims 1
- 235000020778 linoleic acid Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0221480.7A GB0221480D0 (en) | 2002-09-16 | 2002-09-16 | Treatment of anorexia nervosa (AN) and bulimia |
| PCT/GB2003/003985 WO2004024136A1 (en) | 2002-09-16 | 2003-09-16 | Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006503031A JP2006503031A (ja) | 2006-01-26 |
| JP2006503031A5 true JP2006503031A5 (OSRAM) | 2006-11-02 |
Family
ID=9944164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004535695A Pending JP2006503031A (ja) | 2002-09-16 | 2003-09-16 | 拒食症（ａｎ）及び過食症を治療するためのエイコサペンタエン酸（ｅｐａ） |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20060135608A1 (OSRAM) |
| EP (1) | EP1556028A1 (OSRAM) |
| JP (1) | JP2006503031A (OSRAM) |
| KR (1) | KR20050042823A (OSRAM) |
| CN (1) | CN1694694A (OSRAM) |
| AU (1) | AU2003269138A1 (OSRAM) |
| BR (1) | BR0317857A (OSRAM) |
| CA (1) | CA2499142A1 (OSRAM) |
| GB (1) | GB0221480D0 (OSRAM) |
| HR (1) | HRP20050245A2 (OSRAM) |
| IS (1) | IS7744A (OSRAM) |
| MX (1) | MXPA05002943A (OSRAM) |
| NO (1) | NO20051847L (OSRAM) |
| NZ (1) | NZ538793A (OSRAM) |
| PL (1) | PL375726A1 (OSRAM) |
| RS (1) | RS20050226A (OSRAM) |
| RU (1) | RU2330653C2 (OSRAM) |
| TW (1) | TW200410682A (OSRAM) |
| WO (1) | WO2004024136A1 (OSRAM) |
| ZA (1) | ZA200502161B (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003048831A (ja) | 2001-08-02 | 2003-02-21 | Suntory Ltd | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| US20070082949A1 (en) * | 2003-11-14 | 2007-04-12 | Hiroaki Ootani | Agent for preventing and treating language disorders |
| JP4993852B2 (ja) | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP5967855B2 (ja) | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および／又はうつ症状の改善作用を有する組成物 |
| JPWO2008081989A1 (ja) | 2006-12-28 | 2010-04-30 | サントリーホールディングス株式会社 | 神経再生剤 |
| US8816110B2 (en) | 2007-02-15 | 2014-08-26 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
| ES2561482T3 (es) | 2007-02-15 | 2016-02-26 | Centre De Recherche Sur Les Biotechnologies Marine | Monoglicéridos de ácido graso poliinsaturado, derivados, y sus usos |
| CA2677670C (en) | 2007-03-20 | 2010-08-03 | Centre De Recherche Sur Les Biotechnologies Marines | Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof |
| US8343753B2 (en) | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
| KR102012111B1 (ko) * | 2009-06-15 | 2019-08-19 | 아마린 파마, 인크. | 병용 스타틴 요법을 받는 대상체에서 ｌｄｌ－ｃ 수준을 상승시키지 않으면서 트리글리세리드를 저하시키기 위한 조성물 및 방법 |
| WO2012109539A1 (en) * | 2011-02-11 | 2012-08-16 | E. I. Du Pont De Nemours And Company | An eicosapentaenoic acid concentrate |
| US9447020B2 (en) | 2013-10-31 | 2016-09-20 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
| RU2545988C1 (ru) * | 2013-11-12 | 2015-04-10 | Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр Департамента здравоохранения города Москвы | Способ лечения хронического запора и функциональной анорексии |
| AU2019217673A1 (en) | 2018-02-07 | 2020-09-24 | Scf Pharma Inc. | Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof |
| WO2019204218A1 (en) * | 2018-04-16 | 2019-10-24 | Quadrant Biosciences Inc. | Salivary microrna levels in anorexia nervosa provide a liquid biopsy of metabolic and neuropsychiatric status |
| CN112384212A (zh) | 2018-05-03 | 2021-02-19 | Scf制药股份有限公司 | 多不饱和脂肪酸单甘油酯、其组合物、方法和用途 |
| CN109276262B (zh) * | 2018-07-30 | 2021-01-26 | 中国科学院心理研究所 | 一种用于筛选高危进食障碍的检测系统 |
| US12226390B2 (en) | 2019-07-21 | 2025-02-18 | Scf Pharma Inc. | Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof |
| WO2021195627A1 (en) * | 2020-03-27 | 2021-09-30 | Homeostasis Therapeutics, Limited | Method of treatment for anorexia nervosa, bulimia and related clinical syndromes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9224809D0 (en) * | 1992-11-26 | 1993-01-13 | Scotia Holdings Plc | Schizophrenia |
| US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
| GB9901809D0 (en) * | 1999-01-27 | 1999-03-17 | Scarista Limited | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
-
2002
- 2002-09-16 GB GBGB0221480.7A patent/GB0221480D0/en not_active Ceased
-
2003
- 2003-09-16 AU AU2003269138A patent/AU2003269138A1/en not_active Abandoned
- 2003-09-16 TW TW092125483A patent/TW200410682A/zh unknown
- 2003-09-16 RU RU2005107416/14A patent/RU2330653C2/ru not_active IP Right Cessation
- 2003-09-16 KR KR1020057004483A patent/KR20050042823A/ko not_active Withdrawn
- 2003-09-16 US US10/528,114 patent/US20060135608A1/en not_active Abandoned
- 2003-09-16 CA CA002499142A patent/CA2499142A1/en not_active Abandoned
- 2003-09-16 JP JP2004535695A patent/JP2006503031A/ja active Pending
- 2003-09-16 NZ NZ538793A patent/NZ538793A/en unknown
- 2003-09-16 BR BR0317857-9A patent/BR0317857A/pt not_active IP Right Cessation
- 2003-09-16 PL PL03375726A patent/PL375726A1/xx not_active Application Discontinuation
- 2003-09-16 WO PCT/GB2003/003985 patent/WO2004024136A1/en not_active Ceased
- 2003-09-16 RS YUP-2005/0226A patent/RS20050226A/sr unknown
- 2003-09-16 MX MXPA05002943A patent/MXPA05002943A/es not_active Application Discontinuation
- 2003-09-16 HR HR20050245A patent/HRP20050245A2/hr not_active Application Discontinuation
- 2003-09-16 CN CNA038251698A patent/CN1694694A/zh active Pending
- 2003-09-16 EP EP03750919A patent/EP1556028A1/en not_active Ceased
-
2005
- 2005-03-15 ZA ZA200502161A patent/ZA200502161B/en unknown
- 2005-03-15 IS IS7744A patent/IS7744A/is unknown
- 2005-04-15 NO NO20051847A patent/NO20051847L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006503031A5 (OSRAM) | ||
| ES2613606T3 (es) | Uso de derivados de ácidos grasos polinsaturados como medicamentos | |
| RU2005107416A (ru) | Эйкозапентаеновая кислота (эпк) для лечения нервно-психической анорексии (на) и булимии | |
| US11224585B2 (en) | Compositions containing omega-3 oil and uses thereof | |
| TWI285549B (en) | Therapeutic combinations of fatty acids | |
| CN1245984C (zh) | 用于预防和/或治疗血管疾病的制剂 | |
| JP2020094072A (ja) | ω３脂肪酸の自己乳化組成物 | |
| WO2005089744A3 (en) | Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma | |
| CN1343120A (zh) | 必需脂肪酸在预防心血管疾病中的应用 | |
| JP2014512351A5 (OSRAM) | ||
| EP3157936A1 (en) | Mineral amino-acid complexes of active agents | |
| RU2010120706A (ru) | Композиция липоевой кислоты в виде шариков | |
| WO2005046668A1 (ja) | 言語障害予防・治療剤 | |
| GB2504061A (en) | Omega-6 Enriched PUFA Phospholipids | |
| KR20190118556A (ko) | 악액질의 예방 및/또는 치료용 오메가-3 지방산 조성물 | |
| Singer | ICU nutrition: Treatment and problem solving Topic 18 | |
| Brummer | Probiotics and gut health—Is food passing pharma? | |
| Calder | Immunity on the cutting edge between food and pharma | |
| Ferreira et al. | Effect of oral dose of conglycinin alone and combined with fenofibrate or rosuvastatin in rats fed a high-cholesterol diet |